195 related articles for article (PubMed ID: 33641298)
41. Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency.
Mirsafian H; Ripen AM; Leong WM; Chear CT; Bin Mohamad S; Merican AF
Sci Rep; 2017 Jul; 7(1):6836. PubMed ID: 28754963
[TBL] [Abstract][Full Text] [Related]
42. Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults.
Usui K; Sasahara Y; Tazawa R; Hagiwara K; Tsukada S; Miyawaki T; Tsuchiya S; Nukiwa T
Respir Res; 2001; 2(3):188-92. PubMed ID: 11686883
[TBL] [Abstract][Full Text] [Related]
43. Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.
Bucciol G; Moens L; Payne K; Wollants E; Mekahli D; Levtchenko E; Vermeulen F; Tousseyn T; Gray P; Ma CS; Tangye SG; Van Ranst M; Brown JR; Breuer J; Meyts I
J Clin Immunol; 2018 Oct; 38(7):748-752. PubMed ID: 30311057
[No Abstract] [Full Text] [Related]
44. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
45. Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
Srinivasan C; Shameli A; Ritchie B; Adatia A
Immun Inflamm Dis; 2023 Oct; 11(10):e1049. PubMed ID: 37904676
[TBL] [Abstract][Full Text] [Related]
46. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.
Tóth B; Volokha A; Mihas A; Pac M; Bernatowska E; Kondratenko I; Polyakov A; Erdos M; Pasic S; Bataneant M; Szaflarska A; Mironska K; Richter D; Stavrik K; Avcin T; Márton G; Nagy K; Dérfalvi B; Szolnoky M; Kalmár A; Belevtsev M; Guseva M; Rugina A; Kriván G; Timár L; Nyul Z; Mosdósi B; Kareva L; Peova S; Chernyshova L; Gherghina I; Serban M; Conley ME; Notarangelo LD; Smith CI; van Dongen J; van der Burg M; Maródi L
Mol Immunol; 2009 Jun; 46(10):2140-6. PubMed ID: 19419768
[TBL] [Abstract][Full Text] [Related]
47. Clinical and mutational features of X-linked agammaglobulinemia in Mexico.
García-García E; Staines-Boone AT; Vargas-Hernández A; González-Serrano ME; Carrillo-Tapia E; Mogica-Martínez D; Berrón-Ruíz L; Segura-Mendez NH; Espinosa-Rosales FJ; Yamazaki-Nakashimada MA; Santos-Argumedo L; López-Herrera G
Clin Immunol; 2016 Apr; 165():38-44. PubMed ID: 26960951
[TBL] [Abstract][Full Text] [Related]
48. Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.
Madathil Govindaraj G; Jain A; Edavazhippurath A; Bhoyar RC; Dhanasooraj D; Mishra A; Gupta V; Nair M; Shiny PM; Uppuluri R; Kumar A; Kashyap A; Ajith Kumar VT; Shankaran G; Senthivel V; Imran M; Kumar Divakar M; Sawant S; Dalvi A; Madkaikar M; Raj R; Sivasubbu S; Scaria V
Hum Immunol; 2022 Apr; 83(4):335-345. PubMed ID: 35074268
[TBL] [Abstract][Full Text] [Related]
49. Concomitant diagnosis of immune deficiency and
Sanford E; Farnaes L; Batalov S; Bainbridge M; Laubach S; Worthen HM; Tokita M; Kingsmore SF; Bradley J
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559311
[TBL] [Abstract][Full Text] [Related]
50. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
Luk ADW; Ni K; Wu Y; Lam KT; Chan KW; Lee PP; Tu W; Mao H; Lau YL
Front Immunol; 2018; 9():1826. PubMed ID: 30147693
[TBL] [Abstract][Full Text] [Related]
51. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
52. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
Çekiç Ş; Özgür T; Karalı Y; Özkan T; Kılıç SŞ
Turk J Pediatr; 2019; 61(6):937-940. PubMed ID: 32134589
[TBL] [Abstract][Full Text] [Related]
53. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia.
Mohammad T; Amir M; Prasad K; Batra S; Kumar V; Hussain A; Rehman MT; AlAjmi MF; Hassan MI
Int J Biol Macromol; 2020 Dec; 164():2399-2408. PubMed ID: 32784026
[TBL] [Abstract][Full Text] [Related]
54. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
[TBL] [Abstract][Full Text] [Related]
55. Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia.
Vu QV; Wada T; Le HT; Le HT; Van Nguyen AT; Osamu O; Yachie A; Nguyen SN
BMC Pediatr; 2014 May; 14():129. PubMed ID: 24885015
[TBL] [Abstract][Full Text] [Related]
56. Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.
Pérez de Diego R; López-Granados E; Rivera J; Ferreira A; Fontán G; Bravo J; García Rodríguez MC; Bolland S
Clin Exp Immunol; 2008 Apr; 152(1):33-8. PubMed ID: 18241233
[TBL] [Abstract][Full Text] [Related]
57. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
[TBL] [Abstract][Full Text] [Related]
58. Hemizygous BTK Gene Variant Causing X-Linked Agammaglobulinemia in Two Siblings.
Saheb Sharif-Askari N; Hafezi S; Saheb Sharif-Askari F; Frommenwiler N; Halwani R
J Clin Immunol; 2023 Oct; 43(7):1533-1536. PubMed ID: 37341860
[No Abstract] [Full Text] [Related]
59. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
60. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]